149 related articles for article (PubMed ID: 20555139)
1. Severe In vivo hyper-homocysteinemia is not associatedwith elevation of amyloid-beta peptides in the Tg2576 mice.
Zhuo JM; Praticò D
J Alzheimers Dis; 2010; 21(1):133-40. PubMed ID: 20555139
[TBL] [Abstract][Full Text] [Related]
2. Acceleration of brain amyloidosis in an Alzheimer's disease mouse model by a folate, vitamin B6 and B12-deficient diet.
Zhuo JM; Praticò D
Exp Gerontol; 2010 Mar; 45(3):195-201. PubMed ID: 20005283
[TBL] [Abstract][Full Text] [Related]
3. Folate/Vitamin B Alleviates Hyperhomocysteinemia-Induced Alzheimer-Like Pathologies in Rat Retina.
Guo J; Ni S; Li Q; Wang JZ; Yang Y
Neurosci Bull; 2019 Apr; 35(2):325-335. PubMed ID: 30264378
[TBL] [Abstract][Full Text] [Related]
4. Diet-induced hyperhomocysteinemia increases amyloid-beta formation and deposition in a mouse model of Alzheimer's disease.
Zhuo JM; Portugal GS; Kruger WD; Wang H; Gould TJ; Pratico D
Curr Alzheimer Res; 2010 Mar; 7(2):140-9. PubMed ID: 19939226
[TBL] [Abstract][Full Text] [Related]
5. Transthyretin accelerates vascular Abeta deposition in a mouse model of Alzheimer's disease.
Wati H; Kawarabayashi T; Matsubara E; Kasai A; Hirasawa T; Kubota T; Harigaya Y; Shoji M; Maeda S
Brain Pathol; 2009 Jan; 19(1):48-57. PubMed ID: 18429966
[TBL] [Abstract][Full Text] [Related]
6. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice.
Hedberg MM; Clos MV; Ratia M; Gonzalez D; Lithner CU; Camps P; Muñoz-Torrero D; Badia A; Giménez-Llort L; Nordberg A
Neurodegener Dis; 2010; 7(6):379-88. PubMed ID: 20689242
[TBL] [Abstract][Full Text] [Related]
7. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
[TBL] [Abstract][Full Text] [Related]
8. Microglial-associated responses to comorbid amyloid pathology and hyperhomocysteinemia in an aged knock-in mouse model of Alzheimer's disease.
Braun DJ; Dimayuga E; Morganti JM; Van Eldik LJ
J Neuroinflammation; 2020 Sep; 17(1):274. PubMed ID: 32943069
[TBL] [Abstract][Full Text] [Related]
9. Early hyperactivity in lateral entorhinal cortex is associated with elevated levels of AβPP metabolites in the Tg2576 mouse model of Alzheimer's disease.
Xu W; Fitzgerald S; Nixon RA; Levy E; Wilson DA
Exp Neurol; 2015 Feb; 264():82-91. PubMed ID: 25500142
[TBL] [Abstract][Full Text] [Related]
10. The Herp protein pathway is not involved in the pro-amyloidogenic effect of hyperhomocysteinemia.
Zhuo JM; Kruger WD; Praticò D
J Alzheimers Dis; 2010; 20(2):569-76. PubMed ID: 20164556
[TBL] [Abstract][Full Text] [Related]
11. High levels of homocysteine results in cerebral amyloid angiopathy in mice.
Li JG; Praticò D
J Alzheimers Dis; 2015; 43(1):29-35. PubMed ID: 25061050
[TBL] [Abstract][Full Text] [Related]
12. beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease.
Terai K; Iwai A; Kawabata S; Tasaki Y; Watanabe T; Miyata K; Yamaguchi T
Neuroscience; 2001; 104(2):299-310. PubMed ID: 11377835
[TBL] [Abstract][Full Text] [Related]
13. X11alpha haploinsufficiency enhances Abeta amyloid deposition in Alzheimer's disease transgenic mice.
Saluja I; Paulson H; Gupta A; Turner RS
Neurobiol Dis; 2009 Oct; 36(1):162-8. PubMed ID: 19631749
[TBL] [Abstract][Full Text] [Related]
14. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model.
Lim GP; Calon F; Morihara T; Yang F; Teter B; Ubeda O; Salem N; Frautschy SA; Cole GM
J Neurosci; 2005 Mar; 25(12):3032-40. PubMed ID: 15788759
[TBL] [Abstract][Full Text] [Related]
15. Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice.
Plaschke K; Kopitz J; Siegelin M; Schliebs R; Salkovic-Petrisic M; Riederer P; Hoyer S
J Alzheimers Dis; 2010; 19(2):691-704. PubMed ID: 20110613
[TBL] [Abstract][Full Text] [Related]
16. An increase in Abeta42 in the prefrontal cortex is associated with a reversal-learning impairment in Alzheimer's disease model Tg2576 APPsw mice.
Zhuo JM; Prakasam A; Murray ME; Zhang HY; Baxter MG; Sambamurti K; Nicolle MM
Curr Alzheimer Res; 2008 Aug; 5(4):385-91. PubMed ID: 18690835
[TBL] [Abstract][Full Text] [Related]
17. Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer's disease.
Dutescu RM; Li QX; Crowston J; Masters CL; Baird PN; Culvenor JG
Graefes Arch Clin Exp Ophthalmol; 2009 Sep; 247(9):1213-21. PubMed ID: 19271231
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease.
Mori T; Koyama N; Arendash GW; Horikoshi-Sakuraba Y; Tan J; Town T
Glia; 2010 Feb; 58(3):300-14. PubMed ID: 19705461
[TBL] [Abstract][Full Text] [Related]
19. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
Bi Oh S; Suh N; Kim I; Lee JY
Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
[TBL] [Abstract][Full Text] [Related]
20. Secretion and accumulation of Abeta by brain vascular smooth muscle cells from AbetaPP-Swedish transgenic mice.
Frackowiak J; Miller DL; Potempska A; Sukontasup T; Mazur-Kolecka B
J Neuropathol Exp Neurol; 2003 Jun; 62(6):685-96. PubMed ID: 12834113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
